Proteome profiling reveals HES1-driven mitotic catastrophe in ovarian serous carcinoma
Jie Bao, Sanna Pikkusaari, Jun Dai…·Jing Ping Tang
This study identifies BX-912 as a therapeutic agent for ovarian serous carcinoma, revealing HES1 as a target and showing synergistic effects with olaparib.